from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2954c/-

LFCtreatmentdescriptionclass of inhibitor

0.359

Amikacinug/mL Amikacintranslation

1.153

Cap5-10ug/mL Capreomycintranslation

0.675

Rox10-50 ug/mL Roxithromycintranslation

1.152

SM2-5 ug/mL Streptomycintranslation

1.439

Tet5-10 ug/mL Tetracyclinetranslation

-0.305

Rif0.2-5ug/mL Rifampicintranscription

-0.115

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.192

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.064

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.615

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.964

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.067

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.243

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.852

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.107

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.087

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.390

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.591

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.218

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.072

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.126

KCN5-20 ug/mL Potassium cyaniderespiration

-0.790

NaN30.2-2 mM Sodium aziderespiration

0.426

Nigericin50 uM Nigericinrespiration

-0.914

TRC10-150 ug/mL Triclosanrespiration

-1.637

TRZ10-25 ug/mL Thioridazinerespiration

-0.817

Valinomycin0.5-10 uM Valinomycinrespiration

0.038

ZnSO42 mM ZnSO4respiration

0.047

menadione6-10 ug/mL Menadionerespiration

0.437

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.785

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.288

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.379

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.560

NRP_1Non-replicating persistence stage 1dosRassociated

0.839

Amp0.2mg/mL AmpicillincellWall

0.626

Cephalexin20-100 ug/mL CephalexincellWall

1.110

Cerulenin0.32-5 ug/mL CerulenincellWall

0.457

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.725

EMB10-20 ug/mL EthambutolcellWall

1.038

Eta12-40 ug/mL EthionamidecellWall

0.958

INH0.2-0.4 ug/mL IsoniazidcellWall

0.632

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.043

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.147

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.764

BZA0.12 mg/mL BenzamidearomaticAmides

-0.270

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.210

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.099

H2O24 mM hydrogen peroxideDNAdamaging

0.305

Levo10 ug/mL LevofloxacinDNAdamaging

0.945

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.342

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.696

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.658

UVUV-irradiationDNAdamaging

-0.420

ARP41-4 ug/mL Antitubercular compound ARP4?

0.454

Antimycin12.5-50 ug/mL Antimycin A?

1.116

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.092

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.079

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.577

PA8240.2-2 ug/mL PA-824?

-1.241

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.094

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.876

Verapamil50 uM Verapamil?

0.534

mercaptoethanol2 mM 2-Mercaptoethanol?

0.619

methoxatin10-20 ug/mL Methoxatin?